Consumer goods giant Reckitt Benckiser said it has agreed to pay up to $1.4bn to settle US investigations into the sale and marketing of an opioid addiction treatment by its former pharmaceuticals business Indivior.
Source: Sky Business News
Consumer goods giant Reckitt Benckiser said it has agreed to pay up to $1.4bn to settle US investigations into the sale and marketing of an opioid addiction treatment by its former pharmaceuticals business Indivior.
Source: Sky Business News